Paper Details

  1. Home
  2. Paper Details

Adjuvant systemic therapy of stage I and II breast cancer.

Author: GoodmanM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Adjuvant systemic therapy has been proven effective for both node-positive and node-negative breast cancer patients. However, some women with favorable prognoses still experience recurrence. Identifying high-risk patients for recurrence and developing targeted treatments are ongoing research priorities.
Paper Details　
Original Abstract of the Article :
The value of adjuvant systemic therapy has been clearly demonstrated in both node-positive and node-negative patients. However, there are many women with favorable prognoses whose breast cancer recurs. It has been possible only recently to identify subsets of patients who are at definite risk for re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0749-2081(91)90030-s

データ提供：米国国立医学図書館（NLM）

Adjuvant Systemic Therapy for Early-Stage Breast Cancer: A Complex Landscape

This research delves into the [complexities of adjuvant systemic therapy] for [stage I and II breast cancer]. The study aims to [assess the value and efficacy of adjuvant therapy in both node-positive and node-negative patients] and to [identify subsets of patients at high risk for recurrence].

Adjuvant Therapy: A Crucial Tool for Breast Cancer Management

The study underscores the importance of [adjuvant systemic therapy in improving outcomes for patients with early-stage breast cancer]. The findings emphasize the need for [continued research to refine the selection criteria and treatment strategies] for this diverse group of patients.

Optimizing Treatment for Early-Stage Breast Cancer

This research provides valuable insights into the [challenges and opportunities] associated with [adjuvant systemic therapy for early-stage breast cancer]. The study highlights the need for [a personalized approach to treatment] based on the individual patient's risk factors and characteristics.

Dr. Camel's Conclusion

The journey through the desert of breast cancer research is a long and winding one. This research, like a trusty camel carrying essential supplies, helps us navigate the complex terrain of adjuvant therapy. It's a reminder that even in the face of such a serious disease, there are tools and strategies that can improve outcomes. The study highlights the importance of individualized treatment plans and ongoing research to ensure that every patient receives the best possible care.
Date :
  1. Date Completed 1991-11-20
  2. Date Revised 2019-10-28
Further Info :

Pubmed ID

1833804

DOI: Digital Object Identifier

10.1016/0749-2081(91)90030-s

Related Literature

Article Analysis
・Effective treatment of breast cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.